Using a recent survey on the adoption of AI/ML conducted by the Tufts CSDD as context, pharma leaders discussed how they are using these technologies to optimize trial execution.

During a live event, Mojtaba Akhtari, MD, discussed the goals and treatment approach for patients with low-risk polycythemia ...

UBS upgraded Alkermes (NASDAQ:ALKS) to Buy from Neutral on Tuesday, citing prospects for Irish biotech’s orexin 2 receptor ...

1 (tie), Yealimi Noh and Haeran Ryu, .78%. 3 (tie), Nanna Koerstz Madsen and Rio Takeda, .77%. 5 (tie), Allisen Corpuz, Hannah Green and Rose Zhang, .76%. 8, 3 tied with .75%.

June 6-8 _ ShopRite LPGA Classic Presented by Acer (Jennifer Kupcho) June 12-15 _ Meijer LPGA Classic for Simply Give (Carlota Ciganda) June 26-29 _ Dow Championship, Midland, Mich. July 10-13 _ The ...

The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...

CLARKSBURG, W.Va (WDTV) - A business in Clarksburg has made the decision to close its doors permanently. BioLife Plasma ...

With the FDA's approval of hereditary angioedema preventative treatment Andembry, CSL is ready to take on Takeda’s ...

Factor XIIa inhibitor Andembry (garadacimab) has been cleared in the US for use in patients aged 12 and over with HAE, which ...

The sequence of colorectal cancer (CRC) diagnosis matters for patients with multiple primary cancers. Patients diagnosed ...

Korakuen Hall is playing host to the Death Pain Invitational special on June 24th which is going to be headlined by El ...